Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2126-2133

  Jiang, Jian Dong ^a   Wang, Yue ^a   Roboz, John ^a   Strauchen, James ^a   Holland, James F ^a   Bekesi, J George ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMOACETYLAMINOBENZOYLUREA; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN 3T3; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DNA FRAGMENTATION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; NEOPLASMS; TUBULIN; TUMOR CELLS, CULTURED; UREA;

EID: 0032523959     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rowinsky, E. K., and Donehower, R. C. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol. Ther., 52: 35-84, 1991.
2. Sluder, G. The practical use of colchicine and colcemid to reversibly block microtubule assembly in living cells. In: K. W. Adolph (ed.), Advanced Techniques in Chromosome Research, pp. 427-447. New York: Marcel Dekker, 1991.
3. Mareel, M. M., and DeMets, M. Effect of microtubule inhibitors on invasion and on related activities of tumor cells. Int. Rev. Cytol., 90: 125-168, 1984.
4. Donehower, R. C., and Rowinsky, E. K. An overview of experience with Taxol (paclitaxel) in the U. S. A. Cancer Treatment Rev., 19 (Supplement C): 63-78, 1993.
5. Forsyth, P., Cairncross, G., Stewart, D., Goodyear, M., Wainman, N., and Eisenhauer, E. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trial Group. Invest. New Drugs., 14: 203-206, 1996.
6. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. The cytoskeleton. In: B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson (eds.), Molecular Biology of The Cell, pp. 787-861. New York: Garland Publishing Inc., 1994.
7. Stein, G. S., Stein, J. L., and Lian, J. B. Cell cycle and growth control. J. Cell. Biochem., 54: 373-374, 1994.
8. Carr, A. M. Checkpoints take the next step. Science (Washington DC), 271; 314-315, 1996.
9. Banerjee, R., Bekesi, J. G., Tarcsafalvi, A., Sperber, K., Deak, G., Choi, H. S. H., Paronetto, F., Holland, J. F., and Acs, G. Productive non-lytic HIV-1 replication in a newly established human leukemic cell line. Proc. Natl. Acad. Sci. USA, 89: 9996-1000, 1992.
10. Bekesi, G. J., Banerjee, R., Jiang, J. D., Roboz, J. P., Tarcsafalvi, A., Holland, J. F., and Acs, G. Translocation of cytoplasmic antigen markers in a biphenotypic cell line derived from a patient with myelodysplastic syndrome. Mol. Cell. Differ., 3: 111-123, 1995.
11. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
12. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V. Apoptosis: its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
13. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role for c-myc in apoptotic cell death in T-cell hybridomas. Science (Washington DC), 257: 212-214, 1992.
14. Fincham, V. J., Unlu, M., Brunton, V. G., Pitts, J. D., Wyke, J. A., and Frame, M. C. Translocation of Src kinase to the cell periphery is mediated by the actin cytoskeleton under the control of the Rho family of small G proteins. J. Cell Biol., 135: 1551-1564, 1996.
15. Munemitsu, S., Souza, B., Muller, O., Albert, I., Rubinfeld, B., and Polakis, P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res., 54: 3676-3681, 1994.
16. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B., and Kinzler, K. W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res., 54: 3672-3675, 1994.
17. Bhattacharya, G., and Boman, B. M. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells. Biochem. Biophys. Res. Commun., 208: 103-110, 1995.
18. Nathke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., and Nelson, W. J. The adenomatous polyposis coli suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol., 134: 165-179, 1996.
19. Blagosklonny, M. V., Giannakakou, P., el-Deiry, W. S., Kingston, D. G., Higgs, P. I. Neckers, L., and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57: 130-135, 1997.
20. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
21. Fromes, Y., Gounon, P., Veitia, R., Bissery, M. C., and Fellous, A. Influence of microtubule-associated proteins on the differential effects of paclitaxel and docetaxel. J. Protein Chem., 15: 377-388, 1996.
22. Garcia, P., Braguer, D., Carles, G., El Khyari, S., Barra, Y., de Ines, C., Barasoain, I., and Briand, C. Comparative effects of Taxol and Taxotere on two different human carcinoma cell lines. Cancer Chemother. Pharmacol., 34: 335-343, 1994.
23. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
24. Murray, A. W. Creative blocks: cell-cycle checkpoints and feedback control. Nature (Lond.), 359: 599-604, 1992.
25. Minshull, J., Sun, H., Tonks, N. K., and Murray, A. W. A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts. Cell, 79: 475-486, 1995.
26. Li, R., and Murray, A. W. Feedback control of mitosis in budding yeast. Cell, 66: 519-531, 1991.
27. Hoyt, M. A., Totis, L., and Roberts, B. T. S. Cervisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell, 66: 507-517, 1991.
28. Malawista, S. E., Bensch, K. G., and Sato, H. Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science (Washington DC), 160: 770-772, 1968.
29. Schiff, P. B., Fant, J., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
30. Ando, N., Nakajima, T., Masuda, H., Kawabata, Y., Iwai, M., Watanabe, M., Kagitani, Y., Yamada, N., and Tsukagoshi, S. Antimicrotubule effects of the novel antitumor benzoylphenylurea derivative HO-221. Cancer Chemther. Pharmacol., 35: 63-69, 1995.
31. Etievan, C., Schambel, P., Rigaud, S., Barret, J. M., Limouzy, A., Guminski, Y., Cugnasse, S., Imbert, T., and Hill, B. T. 3D structure-activity relationships of tubulin inhibitors with no Pgp recognition. Proc. Am. Assoc. Cancer Res., 38: 602, 1997.
32. Rowinsky, E. K., Donehower, R. C., Jones, R. J., and Tucker, R. W. Microtubule changes and cytotoxicity in leukemia cell lines treated with Taxol. Cancer Res., 48: 4093-4100, 1988.
33. Manfredi, J. J., and Horwitz, S. B. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther., 25: 83-125, 1984.
34. Roberts, J. R., Rowinsky, E. K., Donehower, R. C., Robertson, J., and Allison, D. C. Demonstration of the cell cycle positions of Taxol-induced "asters" and "bundles" by sequential measurements of autoradiographic labeling of Taxol-sensitive and -resistant cells. J. Histochem. Cytochem., 37: 1659-1665, 1989.
35. Jordan, M. A., Thrower, D., and Wilson, L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles: implications for the role of microtubule dynamics in mitosis. J. Cell Sci., 102: 401-416, 1992.
36. Huang, Y., Ibrado, A. M., Reed, J. C., Bullock, G., Ray, S., Tang, C., and Bhalla, K. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia (Baltimore), 11: 253-257, 1997.
37. Dey, S., Ramachandra, M., Pastan, I., Gottesman, M. M., and Ambudkar, S. V. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. USA, 94: 10594-10599, 1997.